Martin Health System Unveils Xenex Germ-Zapping Robot™ more

Jesuit High School Alumnus Donates Xenex Germ-Zapping Robot to His Alma Mater more

BiO2 Medical Announces Successful Completion of the Angel® Catheter Pivotal Clinical Trial more

Xenex Awarded Premier, Inc. Group Purchasing Contract to Offer Germ-Zapping Robot™ Room Disinfection Technology to Premier Member Hospitals more

SA bioscience companies strike new deal to expand scope of stem cell research more

TFS Corporation share price flat despite soaring earnings more

TFS Corporation doubles quarterly profit more

Innovation makes money grow on trees more

Xenex Germ-Zapping Robot™ Destroys Ebola Virus & Anthrax Spores in New Study Performed at Texas Biomed Biosafety Level 4 Lab more

Indian sandalwood oil producer ramps up production to supply new markets more

Cytocentrics Inc. wins Innovator Award at recent event more

Key Opinion Leader (KOL) Calls for New Standard to Close Port-Site Hernias in Lap and Robotic Surgeries more

Surgical Site Infections Decrease 100% after Trinity Medical Center Implements Infection Control Bundle more

Court Order Requires Tru-D to Cease False and Misleading Statements more

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration more

San Antonio biotech firm CEO is heading west more

Sandalwood grower smells a fortune more

Explore the UV LED market that is expected to reach USD 369.58 million by 2020 more

Ten Life Sciences Companies to Watch in Central Texas more

San Antonio’s Xenex signs national contract with HealthTrust more

Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio more

Benzac® Intensive Spot Treatment Named Best Acne Treatment of 2015 by HEALTH Magazine more

neoSurgical® Reports Commercial Milestone of 2000 US Procedures more

Launch of latest hyaluronic acid based filler range more

Galderma Laboratories Announces the Nationwide Availability of Benzac® more

BioMed SA Celebrates 10th Anniversary more

TFS completes US pharma acquisition more

Finally, Good News for Anyone Looking for a Gentle Acne Treatment more

4th Peer-Reviewed Study to Credit Xenex Germ-Zapping Robots for Infection Rate Decrease more

A pair of biotech VCs take aim at raising SA’s status more

BiO2 Medical raises $4M for device that prevents embolism more

How SA landed Cytocentrics more

Sandalwood firm sticks to forecasts more

Two New Studies Show Decrease in Hospital Acquired Infections after Xenex Germ-Zapping Robots Used for Room Disinfection more

Xenex Offers Industry’s First HAI Reduction Guarantee; Multiple Hospitals Report Decrease in Infection Rates When Using Xenex Germ-Zapping Robots for Room Disinfection more

Xenex to expand sales of ‘germ-zapping robots’ to more European nations more

West Australian Indian sandalwood oil producer purchases American drug companies more

Sandlewood grower to buy US-based pharmaceutical firms more

Cytocentrics has big plans for San Antonio more

TFS Corporation Limited jumps on acquisitions: What you need to know more

Australian firm acquires multiple San Antonio bioscience companies; Deal could be worth $270 million more

TFS To Acquire ViroXis And Santalis Pharma - Quick Facts more

DNAtrix Collaborators Present Data on a Novel Oncolytic Adenovirus Expressing OX40 Ligand that Promotes Antitumor Immunity more

San Antonio expected to become bigger global research player as result of Cytocentrics deal more

Cytocentrics Wins $1 Million Incentive and Warm Welcome to San Antonio more

San Antonio approves major incentive deal to lure German biotech firm more

German Biosciences Company Relocating Headquarters to San Antonio more

Cytocentrics looking to relocate HQ to San Antonio, create 300 jobs more

Cytocentrics CEO: Biotech company passed up bigger financial offers to move to San Antonio more

Milwaukee VA center cleared to use germ-zapping robots more

GAO Affirms VA Contract for Mercury-Free UV Disinfection System, Milwaukee VA Hospital Orders Xenex Full-Spectrum™ Germ-Zapping Robots™ more

Pivotal Investigation of BiO2 Medical's Angel Catheter Exceeds Enrollment Expectations more

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer more

Here’s why these 4 companies are soaring higher today more

Harvard gets wood more

2 Works for You helps teen diagnosed with brain cancer denied access to experimental treatment more

Harvard University sees the good oil in NT sandalwood plantation more

San Antonio bioscience companies to team up on critical research more

Germ-zapping R2-D2 look-alike works at Renown more

Are TFS Corporation Limited shares an absolute bargain? more

Med tech start-up exits Bank of Ireland Seed Fund with US$21m valuation more

Galway-based NeoSurgical exits Kernel Capital more

Xenex sells Germ-Zapping robot to Iowa nonprofit hospital more

Broadlawns Employs Xenex Robot to Eradicate Germs more

Benzac® Acne Solutions Premieres Its First-Ever “Insta-Dramedy” Webseries more

Sandalwood grower enlists F1 star more

StemBioSys closes $8m in funding to help launch its stem cell culture system more

Irish start-up neoSurgical has just signed an exclusive distribution deal for the US market. But, as founder and CEO Barry Russell explains, it has taken persistence and courage to get the company this far more

Xenex exporting hospital-cleaning robots to Europe more

Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection more

Takes $8M to Build Homes For Stem Cells more

San Antonio biomedical company StemBioSys scores major funding more

Lexington Fire Department chosen to conduct trial on new EMS Equipment more

Xenex Rebuts Clorox Attack Following NAD Press Release

SAN ANTONIO--(BUSINESS WIRE)--The Clorox Company has tried to limit Xenex Disinfection Services’ ability to advertise the benefits of Xenex's Germ-Zapping Robot™ in comparison to competing mercury bulb ultraviolet (UV) light disinfection devices. In response, Xenex filed a declaratory judgment action against Clorox. The action asks the court to declare that Xenex may state that the Xenex robot contains “no toxic mercury” and that the Xenex robot is “faster than competing mercury devices.”

Clorox and Xenex offer competing portable UV room disinfection devices used by healthcare facilities. The Clorox Healthcare Optimum-UV System uses bulbs that contain mercury to create UV light while Xenex Germ-Zapping Robots use pulsed xenon, an environmentally friendly, non-toxic inert gas, to create broad spectrum UV light.

Neither Clorox nor any other mercury UV company has a peer-reviewed published study that shows it has reduced healthcare associated infection (HAI) rates, regardless of how long the mercury UV devices are used. Xenex is the only UV company with peer-reviewed, published outcome studies showing reductions in Clostridium difficile (C.diff), MRSA and/or MDRO (multi-drug resistant organism) infection rates greater than 50 percent at hospitals using its technology.

NAD – National Advertising Division
In Dec. 2014, Clorox challenged Xenex's marketing claims through the National Advertising Division (NAD) which is a part of a “self-regulatory” body used by large consumer product companies to resolve advertising disputes. The NAD issued a press release on March 5, 2015 with the headline “Xenex Discontinues Claims for ‘Germ-Zapping Robots’ Following NAD Inquiry; Claims at Issue – Including Ebola Disinfectant Claims – Challenged by Clorox.”

“When we looked at the complaints brought by Clorox over specific statements on the Xenex website, we decided to replace those claims objected to by Clorox with more specific language based on recent studies that focus on the science of our technology and our customers’ success in reducing their infection rates,” said Morris Miller, CEO of Xenex. “We informed the NAD that Xenex had ceased using the express statements complained of by Clorox and thought that ended the matter. Clorox subsequently objected to our statements (which they did not challenge in their NAD complaint) indicating that competing UV disinfection devices contain or use bulbs that contain toxic mercury, and that the Xenex germ-zapping robot is faster than mercury UV devices.

“Both statements are accurate. We filed the action to protect our ability to fairly compete in the marketplace.”

Clarification on NAD Claims—Be More Specific
For example, in its NAD complaint, Clorox objected to the statement:
"Mercury bulbs contain elemental mercury, which means they are classified as hazardous and toxic."

Many, but not all, mercury bulbs are classified as hazardous waste. The mercury within these bulbs is toxic, not the bulb itself. Therefore, Xenex altered its wording.
To clarify, Xenex now says,

“Mercury bulbs contain elemental mercury. Mercury is toxic.”
Or: “Mercury bulbs contain toxic mercury.”

Or: "No toxic mercury" (when referring to the Xenex Germ-Zapping Robot’s bulbs).

Toxic Mercury
Mercury is universally recognized as a toxic substance. Hospitals and health organizations are looking for and often require mercury-free solutions. In January 2013, the World Health Organization (WHO) and Health Care Without Harm approved Mercury-Free Healthcare by 2020. In 2009, President Obama signed Executive Order 13514, Federal Leadership in Environmental, Energy, and Economic Performance, which states that the government will promote pollution prevention and the generation of waste by reducing and minimizing the quantity of toxic and hazardous chemicals and materials acquired, used, or disposed of. The bulbs used by Clorox and other mercury UV device providers contain mercury, which is a toxic substance. Special handling is required in the event of bulb breakage and depending upon the applicable state law and the amount of mercury present in the bulb, special rules may apply to disposal. These are important facts that hospitals should understand when selecting a portable room disinfection device.

Faster than Mercury UV Devices
The Xenex robot is designed for speed, effectiveness and ease of use, which allows a hospital’s Environmental Services (EVS) staff to operate the robot without disrupting hospital operations. With a proven five-minute disinfection cycle, the robot can disinfect 30-62 hospital rooms per day (according to Xenex customers), including patient rooms, operating rooms, equipment rooms, emergency rooms, intensive care units and public areas. Nearly 300 hospitals, Veterans Affairs, DoD, skilled nursing facilities, ambulatory surgery centers and long-term acute care facilities use Xenex robots.

The Xenex robot is faster than competing mercury UV products. Based upon both the mercury manufacturers’ recommended run and cool-down times and the peer reviewed literature, which should be referred to for evaluating both speed and efficacy, the Xenex robot is faster. No mercury UV provider recommends a run-time that is less than the five minute Xenex run-time for elimination of C.diff spores, and Xenex does not require any boot-up time or any cool-down time after use, which adds up to 15 additional minutes for mercury devices. While peer-reviewed studies show that the Xenex robot is effective in reducing the amount of C.diff in the patient environment when run in five minute positions, the peer-reviewed studies evaluating mercury UV devices and their ability to disinfect against C.diff spores reference cycle times between 40 and 90 minutes.

The Only UV Disinfection Device Proven to Work in the Hospital Environment.
In the last four years there have been 10 peer reviewed studies published confirming the efficacy of the Xenex Germ-Zapping Robot™ in the healthcare environment, including three studies showing a decrease in C.diff, MRSA and/or MDRO infections in patients when the hospital utilized the Xenex robot for room disinfection. Xenex is the only UV disinfection provider that has hospital customers publishing infection reduction results in peer-reviewed journals, most with greater than 50 percent decreases in their HAI rates.
 
About Xenex Disinfection Services
Xenex's patented pulsed xenon Full Spectrum UV room disinfection system is a pesticidal device used for the advanced cleaning of healthcare facilities. Due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. The Xenex mission is to eliminate harmful bacteria, viruses and spores that can cause hospital acquired infections in the patient environment, and to become the new standard method for disinfection in healthcare facilities worldwide. For more information, visit www.xenex.com.

Contact Xenex
Melinda Hart, 210-240 4669
melinda.hart@xenex.com

Source: http://www.businesswire.com

April 8th 2015 back

San Antonio’s Xenex files lawsuit against Cloroxn more

Lexington Fire Dept. Among First In Kentucky Testing New Device more

Here’s why today is a good day to buy TFS Corporation Limited shares more

Over-the-counter (OTC) remedies rescue consumers from skin and health issues that are—at the time—more pressing than fine lines and wrinkles more

Germ-zapping Dalek-like robots trialed at King’s Lynn’s Queen Elizabeth Hospital to reduce the spread of infection more

Seven Women Run Tech Startups in San Antonio to Watch more

UV light from robots disinfects hospital rooms more

TFS rises on upgraded guidance more

Biological assets boost valuation for TFS more

NPSF Patient Safety Coalition Welcomes Xenex more

UV Disinfection Equipment Market is Expected to Reach $2.8 Billion by 2020 – Allied Market Research more

Scent of success more

BiO2 Medical Begins Enrollment for the Pivotal Investigation of the Angel® Catheter more

Baptist Health's new germ-zapping robots use untraviolet light as a disinfectant more

Baptist Health adds "cleaning robots" more

The Only Full Spectrum™ Pulsed Xenon UV Disinfection System more

Benzac® Acne Solutions Launches in the US more

State of health care: Xenex CEO says company is winning war against deadly infections more

The Health Cell to present event focusing on San Antonio’s health care and biosciences sector more

San Antonio developing biotech executive talent more

Xenex’s latest funding exceeds expectations, expands international opportunities more

San Antonio bioscience company Xenex secures major funding more

Germ-Zapping Robot Makes House Call for Texas Baby more

Hospitals name their disinfecting robots to add personality more

The robot will clean up now: More hospitals buying automated systems to reduce infections more

New Study Shows Pulsed Xenon UV Light Effective in Reducing C. diff, MRSA and VRE in the Hospital Environment more

Forecast: Three San Antonio biomedical companies to watch in 2015 more

Here’s why these 4 stocks are soaring higher today more

Sandalwood the good oil for US funds more

Oil Investment Could Put A Smile On The Faces Of Harvard Students more

Harvard takes stake in TFS more

Aromatherapy at home can be easy more

TFS up on US acne product launch more

BiO2 Medical Receives IDE Approval to Initiate Pivotal Investigation of the Angel® Catheter more

StemBioSys Inc. to Present at Biotech Showcase™ 2015 more

Galderma Laboratories Launches Its First Over-the-Counter Acne Regimen, Benzac® Acne Solutions more